WO2021052225A1 - Chemical semi-synthesis method for artemisinin - Google Patents

Chemical semi-synthesis method for artemisinin Download PDF

Info

Publication number
WO2021052225A1
WO2021052225A1 PCT/CN2020/114150 CN2020114150W WO2021052225A1 WO 2021052225 A1 WO2021052225 A1 WO 2021052225A1 CN 2020114150 W CN2020114150 W CN 2020114150W WO 2021052225 A1 WO2021052225 A1 WO 2021052225A1
Authority
WO
WIPO (PCT)
Prior art keywords
reaction
dihydroartemisinic
artemisinin
acid
anhydride
Prior art date
Application number
PCT/CN2020/114150
Other languages
French (fr)
Chinese (zh)
Inventor
林星辉
陈伟
郑玲辉
王冠
李俊宇
Original Assignee
浙江海正药业股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 浙江海正药业股份有限公司 filed Critical 浙江海正药业股份有限公司
Publication of WO2021052225A1 publication Critical patent/WO2021052225A1/en

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0093Microreactors, e.g. miniaturised or microfabricated reactors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Definitions

  • the invention relates to the field of bioengineering pharmacy, in particular to a chemical semi-synthetic method of artemisinin.
  • Artemisinin is a sesquiterpene lactone drug with peroxide groups extracted from the stems and leaves of the compound inflorescence plant Artemisia annua. It was discovered by Chinese pharmacist Tu Youyou in 1971.
  • the molecular formula of artemisinin is C 15 H 22 O 5 , and its chemical structure is shown in the following formula (VI):
  • Artemisinin is the most effective anti-malarial drug after pyrimidine, chloroquine, and primaquine, especially for cerebral malaria and anti-quinoline malaria. It has the characteristics of quick-acting and low toxicity. It was once called by the World Health Organization as a drug "The only effective malaria treatment drug in the world". According to statistics, the world's annual sales of artemisinin and its derivatives are as high as US$1.5 billion. In recent years, artemisinin has also shown attractive prospects in the treatment of other diseases such as anti-schistosomiasis, regulating or inhibiting the immune function of body fluids, increasing the conversion rate of lymphocytes, and choleretic, expectorant, antitussive, and asthma. . Therefore, the market prospect of artemisinin is very broad.
  • artemisinin can be obtained through three methods.
  • One is to extract from the plant Artemisia annua. This method is susceptible to the influence of climate and region, and the yield is unstable, which causes the market price of artemisinin to fluctuate greatly;
  • the second method is obtained through chemical total synthesis. The chemical reaction conditions are relatively harsh, the reaction method is complicated, and high-risk and high-toxic reagents are used. Therefore, the method is extremely difficult to industrialize and the cost is high; the third method is to use microorganisms first Artemisinic acid is obtained by fermentation, and artemisinin is obtained by chemical synthesis of artemisinic acid. This method has the advantages of high yield, stable production, low production cost, and green process. The preparation of artemisinin by this method has been It is widely accepted. In 2013, the WHO also approved the artemisinin produced by this process for clinical use.
  • Patent WO2009088404 discloses a method for preparing artemisinin by introducing peroxy bonds with dihydroartemisinic acid as a starting material, sodium molybdate as a catalyst, and hydrogen peroxide as an oxidant.
  • the product obtained by this method has poor selectivity. And there are many by-products, and the final total yield of artemisinin is low, and there is still a certain distance from industrial application.
  • Patent ZL201280042681.7 discloses a method and device for synthesizing artemisinin from dihydroartemisinic acid. Because it irradiates the tube, the mixing effect is uneven, the flux is small, and the efficiency of daily artemisinin production is low, and a large amount of artemisinin production is required for amplification. Pipes require a lot of space and are not easy to industrialize production.
  • Patent ZL201310615102.X discloses a method and equipment for preparing artemisinin on a large scale.
  • the reactor is a chromatography column with a sand core, a glass tube is embedded in the middle of the chromatography column, and a reaction system is set between the chromatography column and the glass tube.
  • the glass tube is equipped with a light source, the reactor has no mixing device, the reaction light is uneven, the temperature is uneven, and the reaction temperature is harsh from -20°C to -50°C, and the reaction time is slow.
  • the existing artemisinin preparation methods have disadvantages such as poor synthesis selectivity, low yield, harsh reaction conditions, and difficulty in scale-up production. Therefore, it is necessary to develop a chemical semi-synthetic process of artemisinin with high production efficiency, high finished product yield and purity, low cost, mild reaction conditions, and industrialization.
  • the present invention provides a chemical semi-synthetic method of artemisinin (VI).
  • the method of the present invention has simple operation, high product yield, good purity, low cost, mild reaction conditions, stable process and easy industrial production.
  • the method includes the following steps:
  • Dihydroartemisinic acid (I) reacts with oxalyl chloride (II) to produce dihydroartemisinyl chloride (III);
  • dihydroartemisinic anhydride (IV) and oxygen undergo a photooxidation reaction under the action of a photocatalyst to obtain the peroxyalcohol (V) of dihydroartemisinic anhydride;
  • Peroxyalcohol (V) and oxygen undergo an oxidative rearrangement reaction under the action of an acid catalyst to obtain artemisinin (VI).
  • the reaction temperature in the step (1) is -10°C to 40°C, preferably 0°C to 30°C, more preferably 10°C to 20°C.
  • the reaction solvent used in the step (1) is one or a mixture of dichloromethane, tetrahydrofuran, toluene, and hexane.
  • the catalyst a used in the step (1) is at least one of N,N-dimethylformamide, tetramethylurea and 1,3 dimethylimidazolinone.
  • the molar ratio of dihydroartemisinic acid (I) to catalyst a in the step (1) is 1:0.001 to 1.
  • the molar ratio of dihydroartemisinic acid (I) to oxalyl chloride (II) in the step (1) is 1:1.01-2.
  • the reaction temperature in the step (2) is -10°C to 20°C, preferably -5°C to 0°C.
  • the reaction solvent used in the step (2) is one or more of dichloromethane, tetrahydrofuran, toluene, and hexane.
  • the catalyst b used in the step (2) is an acid binding agent, preferably at least one of triethylamine, pyridine, and potassium carbonate.
  • the molar ratio of dihydroartemisinyl chloride (III) to dihydroartemisinic acid (I) is 1:1.01 to 1.2.
  • the organic solvent used in the photooxidation reaction in the step (3) is one or more of dichloromethane, toluene, acetonitrile, cyclohexane, and n-heptane.
  • the mass-volume ratio of dihydroartemisinic anhydride (IV) to the organic solvent in the step (3) is 1:2-20 (unit is g/mL), preferably 1:4-6.
  • the photocatalyst in the step (3) is tetraphenylporphyrin or a derivative thereof.
  • the molar ratio of the dihydroartemisinic anhydride (IV) to the photocatalyst is 1:0.001 to 1, preferably 1:0.002 to 0.01.
  • the acid catalyst in the step (3) is a protic acid and or a Lewis acid, preferably trifluoroacetic acid.
  • the molar ratio of dihydroartemisinic anhydride (IV) to the acid catalyst in the step (3) is 1:0.3-2, preferably 1:0.5.
  • the light source used in the photooxidation reaction in the step (3) is an LED light source.
  • the wavelength of the light source is 365-660 nm, preferably 385 nm or 405 nm, more preferably 385 nm.
  • the reaction temperature of the photooxidation reaction in the step (3) is -10°C to 20°C, preferably -5°C to 5°C, more preferably 0°C.
  • the reaction temperature of the oxidative rearrangement reaction in the step (3) is 5°C-60°C, preferably 20°C.
  • the residence time of the photooxidation reaction in the step (3) is 2.9 min to 10.2 min, preferably 4 min to 5.5 min; the residence time of the oxidation rearrangement reaction in the step (3) is 1.7 min ⁇ 5.7min.
  • the flow rate of oxygen in the microchannel reactor in the step (3) is 120 ml/min to 300 ml/min, preferably 160 ml/min to 240 ml/min.
  • the photooxidation reaction and the oxidation rearrangement reaction in the step (3) are continuous reactions, and the pressure of the photooxidation reaction and the oxidation rearrangement reaction are both 0.5-1.7 MPa.
  • the microchannel reactor includes a temperature controller 1, a glass microchannel module 2, a silicon carbide microchannel module 3, a light source 4, an oxygen source 5, feed pumps 7 and 8, and a back pressure valve 9; Among them,
  • the temperature controller 1 is a temperature controller with dual temperature zones
  • the glass microchannel module 2 is made of glass material, is a thin plate square, and has a mixing device with a heart-shaped structure inside;
  • the silicon carbide microchannel module 3 is made of silicon carbide, is a thin plate square, and has a mixing device with a heart-shaped structure inside;
  • the feed pumps 7 and 8 are pumps that can withstand high pressure, preferably KP-22 or Hanbang;
  • the back pressure valve 9 has a back pressure adjustment function.
  • the step 3) also includes further crystallization and purification of the prepared artemisinin, and the crystallization solvent used is one of methanol, ethanol, isopropanol, acetone, methanol and water, ethanol and water Or several, preferably ethanol.
  • the process of converting dihydroartemisinic anhydride into artemisinin of the present invention is carried out in a microchannel reactor as follows: A) singlet oxygen photochemically induces oxidation of dihydroartemisinic anhydride; B) using trifluoroacetic acid Hydrolysis and Hock cracking; C) The oxidation reaction with triplet oxygen produces artemisinin.
  • the continuous type described in the present invention means that the mixed solution containing dihydroartemisinic anhydride flows continuously from the inlet to the outlet of the raw material of the microchannel reactor, and can react continuously, at least in the photooxidation reaction.
  • Artemisinic anhydride is a peroxyalcohol that can be continuously converted to dihydroartemisinic anhydride.
  • the reaction can be continuously transformed, and the outlet of the microchannel reactor can continuously produce products. But it does not mean that the two oxidation reactions occurring in the microchannel reactor cannot be stopped. The reaction is stopped when the light source is adjusted and the oxygen is exhausted.
  • the photooxidation reaction and the oxidation rearrangement reaction carried out in the microchannel reactor of the present invention need to be carried out under pressure.
  • the pure oxygen in the oxygen tank is input, it can promote the advancement of the material liquid in the microchannel reactor, and give a continuous reaction.
  • the microchannel reactor equipment itself also has a back pressure valve (pressurization device). Pressure is extremely important for the efficiency of the photooxidation reaction, and it greatly affects the conversion efficiency of dihydroartemisinic anhydride.
  • the artemisinin prepared according to the method of the present invention has high yield, good purity, and the purity can be as high as 99.5%.
  • the annual throughput of a microchannel reactor using the method of the present invention is 3.5 tons per year. Up to 42 tons/year (calculated as 300 days a year), high throughput, high conversion rate, good reaction liquid mixing effect, stable process, and can be used for mass production.
  • the present invention has the following beneficial effects:
  • the artemisinin product prepared by the process of the present invention has high yield and good purity, and the purity can reach 99.5%.
  • the microchannel reactor used in the process of the present invention has high flux, high conversion rate, good reaction liquid mixing effect, safe and stable process, and can be used for mass production.
  • the photooxidation reaction and the oxidation rearrangement reaction in the microchannel reaction of the present invention have a short reaction time, and the microchannel reactor of the present invention can simultaneously perform the photooxidation reaction and the oxidation rearrangement reaction, further shortening the reaction time.
  • reaction conditions of the present invention are mild.
  • the starting material of the present invention is dihydroartemisinic anhydride. Compared with dihydroartemisinic acid, the carboxylic acid is protected and the side reaction of decarboxylation is inhibited. Dihydroartemisinic anhydride can increase the solubility in organic solvents. , So that the solution is more uniform, so that the light transmission is also more uniform, which is conducive to the photo-oxidation reaction.
  • Figure 1 is a schematic diagram of the structure of the microchannel reactor of the present invention.
  • the reagents and solvents used in the present invention are not particularly limited, and commercially available conventional solvents can be used. It should be emphasized that the meaning or protection scope of the numerical value or numerical endpoint involved in the technical solution of the present invention is not limited to the number itself. Those skilled in the art can understand that they include those that have been widely used in the art. Acceptable allowable error ranges, such as experimental errors, measurement errors, statistical errors and random errors, etc., and these error ranges are all included in the scope of the present invention.
  • the purity of the artemisinin involved in the present invention is detected by high performance liquid chromatography (HPLC).
  • HPLC high performance liquid chromatography
  • Purity refers to the percentage of the chromatographic peak area of the target in the HPLC spectrum to the total peak area.
  • the purity of artemisinin refers to the percentage of the peak area of artemisinin in the HPLC spectrum of the sample.
  • Dihydroartemisinic acid can be commercially available or synthesized.
  • the dihydroartemisinic acid used in this example is prepared from artemisinic acid through a reduction reaction.
  • the microchannel reactor of the present invention includes a temperature controller with dual temperature zone control 1, five glass microchannel modules 2, three silicon carbide microchannel modules 3, a light source 4, an oxygen source 5, and a gas flow Count 6, two feed pumps 7 and 8, a back pressure valve 9, two batching tanks 10 and 11, and a receiving tank 12.
  • the light source 4 irradiates both sides of each glass microchannel module 2 at the same time, which increases the light transmittance of light, as shown by the arrow in Fig. 1;
  • the glass microchannel module 2 is made of glass material and has a thin plate square shape inside.
  • the mixing device with a heart-shaped structure increases the mixing effect of the reaction;
  • the silicon carbide microchannel module 3 is made of silicon carbide and is a thin plate square with a mixing device with a heart-shaped structure inside, which increases the mixing effect of the reaction; temperature controller 1
  • the connected cooling liquid closely adheres to the glass microchannel module 2 and the silicon carbide microchannel module 3, which enhances the heat exchange efficiency of the reaction.
  • the temperature controller 1 has a cooling or heating function
  • the glass microchannel module 2 and the silicon carbide microchannel module 3 are respectively connected to the temperature controller 1 in the dual temperature zone;
  • the reaction liquid flows continuously in the glass microchannel module 2 and the silicon carbide microchannel module 3;
  • the light source 4 is an LED light source
  • the oxygen source 5 is oxygen
  • the gas flow meter 6 is used to adjust the gas flow rate
  • the feed pump 7 is used to feed the photo-oxidation reaction and provide continuous flow force
  • the feed pump 8 is used to feed the oxidation rearrangement reaction and provide power
  • the back pressure valve 9 is used to adjust the pressure
  • the batching tank 10 is used to store dihydroartemisinic anhydride solution, and the batching tank 11 is used to store acid catalysts, such as trifluoroacetic acid;
  • the receiving tank 12 is used to receive the reaction liquid.
  • the residence time is 2.9 minutes
  • the reaction solution is obtained.
  • the reaction solution enters the silicon carbide microchannel module 3, the feed pump 8 is turned on, and trifluoroacetic acid is injected at a flow rate of 0.3ml/min to carry out the oxidation rearrangement reaction.
  • the residence time is 1.7min.
  • the crude artemisinin solution is 590ml, and the oxygen source 5, light source 4, feed pumps 7 and 8, and temperature controller 1 are turned off after receiving.

Abstract

Disclosed is a chemical semi-synthesis method for artemisinin (VI), the method comprising the specific steps of: (1) reacting dihydroartemisinic acid (I) with oxalyl chloride (II) to produce dihydroartemisinyl chloride (III); (2) reacting the dihydroartemisinyl chloride (III) with the dihydroartemisinic acid (I) to produce dihydroartemisinic anhydride (IV) via an acylation reaction; and (3) subjecting the dihydroartemisinic anhydride (IV) to a photo-oxidation reaction and an oxidative rearrangement reaction using a microchannel reactor to prepare the target product, artemisinin (VI). Compared with the prior art, the method has the advantages of high product yield and good product purity, stable process, mild reaction conditions, easy industrial production, etc.

Description

一种青蒿素的化学半合成方法A chemical semi-synthetic method of artemisinin 技术领域Technical field
本发明涉及生物工程制药领域,具体涉及一种青蒿素的化学半合成方法。The invention relates to the field of bioengineering pharmacy, in particular to a chemical semi-synthetic method of artemisinin.
背景技术Background technique
青蒿素是从复合花序植物黄花蒿茎叶中提取的有过氧基团的倍半萜内酯药物,由中国药学家屠呦呦在1971年发现。青蒿素分子式为C 15H 22O 5,其化学结构如下式(VI)所示: Artemisinin is a sesquiterpene lactone drug with peroxide groups extracted from the stems and leaves of the compound inflorescence plant Artemisia annua. It was discovered by Chinese pharmacist Tu Youyou in 1971. The molecular formula of artemisinin is C 15 H 22 O 5 , and its chemical structure is shown in the following formula (VI):
Figure PCTCN2020114150-appb-000001
Figure PCTCN2020114150-appb-000001
青蒿素是继乙氨嘧啶、氯喹、伯喹之后最有效的抗疟疾特效药,尤其是对于脑型疟疾和抗喹啉疟疾,具有速效和低毒的特点,曾被世界卫生组织称作是“世界上唯一有效的疟疾治疗药物”。据统计数据显示,每年全世界对于青蒿素及其衍生物的销售额便多达15亿美元。近些年,青蒿素在抗血吸虫、调节或抑制体液的免疫功能、提高淋巴细胞的转化率,利胆、祛痰、镇咳、平喘等其他疾病的治疗中也显示出诱人的前景。因此,青蒿素市场前景非常广阔。Artemisinin is the most effective anti-malarial drug after pyrimidine, chloroquine, and primaquine, especially for cerebral malaria and anti-quinoline malaria. It has the characteristics of quick-acting and low toxicity. It was once called by the World Health Organization as a drug "The only effective malaria treatment drug in the world". According to statistics, the world's annual sales of artemisinin and its derivatives are as high as US$1.5 billion. In recent years, artemisinin has also shown attractive prospects in the treatment of other diseases such as anti-schistosomiasis, regulating or inhibiting the immune function of body fluids, increasing the conversion rate of lymphocytes, and choleretic, expectorant, antitussive, and asthma. . Therefore, the market prospect of artemisinin is very broad.
目前,青蒿素可以通过三种方法获得,一种是从植物青蒿中提取获得,该方法容易受到气候,地域的影响,且产量不稳定,从而导致青蒿素的市场价格波动较大;第二种方法是通过化学全合成获得,该化学反应条件较为苛刻,反应方法复杂,用到高危高毒试剂,因此,该方法产业化难度极大,成本高昂;第三种方法是先通过微生物发酵获得青蒿酸,再将青蒿酸通过化学合成的方式得到青蒿素,该方法具有产量高,生产稳定,生产成本低,且工艺绿色环保等优点,通过该方法制备青蒿素已经被广泛接受,2013年WHO也批准了该工艺生产的青蒿素应用于临床。At present, artemisinin can be obtained through three methods. One is to extract from the plant Artemisia annua. This method is susceptible to the influence of climate and region, and the yield is unstable, which causes the market price of artemisinin to fluctuate greatly; The second method is obtained through chemical total synthesis. The chemical reaction conditions are relatively harsh, the reaction method is complicated, and high-risk and high-toxic reagents are used. Therefore, the method is extremely difficult to industrialize and the cost is high; the third method is to use microorganisms first Artemisinic acid is obtained by fermentation, and artemisinin is obtained by chemical synthesis of artemisinic acid. This method has the advantages of high yield, stable production, low production cost, and green process. The preparation of artemisinin by this method has been It is widely accepted. In 2013, the WHO also approved the artemisinin produced by this process for clinical use.
从青蒿素的发现至今,由青蒿酸化学半合成青蒿素的报道已有多篇文献描述。M.Jung等曾报道(Tetrahedron Letters,20,5973(1989))青蒿酸经还原处理,获得青蒿醇,再将青蒿醇自氧化制得环状烯醚,再用亚磷酸三苯酯-臭氧化合物处理,获得脱碳青蒿素,但此 工艺复杂,且产率仅为4%。吴毓林也曾报道(J.Chem.Soc,Chem.Commun.,727,1990)青蒿酸合成青蒿素的工艺,其中,由青蒿酸合成青蒿素,反应温度为-70℃~-78℃,反应条件苛刻,收率也比较低,不宜于工业化生产。Since the discovery of artemisinin, there have been many reports on the semi-synthesis of artemisinin from artemisinic acid. M. Jung et al. reported (Tetrahedron Letters, 20, 5973 (1989)) that artemisinic acid was reduced to obtain artemisinol, and then artemisinol was auto-oxidized to produce cyclic enyl ether, and then triphenyl phosphite was used. -Ozone compound treatment to obtain decarburized artemisinin, but the process is complicated and the yield is only 4%. Wu Yulin also reported (J. Chem. Soc, Chem. Commun., 727, 1990) the process of synthesizing artemisinin from artemisinic acid, in which artemisinin is synthesized from artemisinic acid, and the reaction temperature is -70℃~-78 ℃, the reaction conditions are harsh, and the yield is relatively low, which is not suitable for industrial production.
专利WO2009088404公开了以二氢青蒿酸为起始原料,钼酸钠为催化剂,过氧化氢为氧化剂,通过引入过氧键而制备青蒿素的方法,此方法获得的产物选择性较差,且副产物多,最终青蒿素的总收率较低,距离工业化应用尚有一定的距离。Patent WO2009088404 discloses a method for preparing artemisinin by introducing peroxy bonds with dihydroartemisinic acid as a starting material, sodium molybdate as a catalyst, and hydrogen peroxide as an oxidant. The product obtained by this method has poor selectivity. And there are many by-products, and the final total yield of artemisinin is low, and there is still a certain distance from industrial application.
专利ZL201280042681.7公开了一种由二氢青蒿酸合成青蒿素的方法和装置,因其对管子进行光照,混合效果不均一,通量小,日产青蒿素效率低,放大需要大量的管子,需要极大的空间,不易产业化生产。Patent ZL201280042681.7 discloses a method and device for synthesizing artemisinin from dihydroartemisinic acid. Because it irradiates the tube, the mixing effect is uneven, the flux is small, and the efficiency of daily artemisinin production is low, and a large amount of artemisinin production is required for amplification. Pipes require a lot of space and are not easy to industrialize production.
专利ZL201310615102.X公开了一种规模制备青蒿素的方法和设备,其反应器为带砂芯的层析柱,层析柱中间嵌有玻璃管,层析柱和玻璃管之间设反应体系,玻璃管里设光源,该反应器无混合装置,反应光照不均,温度不匀,而且反应温度苛刻为-20℃~-50℃,反应时间慢。Patent ZL201310615102.X discloses a method and equipment for preparing artemisinin on a large scale. The reactor is a chromatography column with a sand core, a glass tube is embedded in the middle of the chromatography column, and a reaction system is set between the chromatography column and the glass tube. , The glass tube is equipped with a light source, the reactor has no mixing device, the reaction light is uneven, the temperature is uneven, and the reaction temperature is harsh from -20°C to -50°C, and the reaction time is slow.
综合所述,现有的青蒿素制备方法存在着合成选择性差、收率低,反应条件苛刻,不易放大生产等缺点。因此,开发出一种生产效率高、成品收率和纯度高、成本低廉、反应条件温和、能够产业化的青蒿素的化学半合成工艺很有必要。In summary, the existing artemisinin preparation methods have disadvantages such as poor synthesis selectivity, low yield, harsh reaction conditions, and difficulty in scale-up production. Therefore, it is necessary to develop a chemical semi-synthetic process of artemisinin with high production efficiency, high finished product yield and purity, low cost, mild reaction conditions, and industrialization.
发明内容Summary of the invention
本发明提供了一种青蒿素(VI)的化学半合成方法,本发明所述方法操作简单、产品收率高、纯度好、成本低廉、反应条件温和、工艺稳定且易于工业化生产,所述方法包括以下步骤:The present invention provides a chemical semi-synthetic method of artemisinin (VI). The method of the present invention has simple operation, high product yield, good purity, low cost, mild reaction conditions, stable process and easy industrial production. The method includes the following steps:
(1)二氢青蒿酸(I)与草酰氯(II)反应,生成二氢青蒿酰氯(III);(1) Dihydroartemisinic acid (I) reacts with oxalyl chloride (II) to produce dihydroartemisinyl chloride (III);
Figure PCTCN2020114150-appb-000002
Figure PCTCN2020114150-appb-000002
(2)二氢青蒿酰氯(III)与二氢青蒿酸(I)进行酰化反应,生成二氢青蒿酸酐(IV);(2) Dihydroartemisinic acid (III) and dihydroartemisinic acid (I) undergo an acylation reaction to generate dihydroartemisinic anhydride (IV);
Figure PCTCN2020114150-appb-000003
Figure PCTCN2020114150-appb-000003
(3)在微通道反应器中,二氢青蒿酸酐(IV)和氧气在光催化剂的作用下进行光氧化反应得到二氢青蒿酸酐的过氧醇(V);二氢青蒿酸酐的过氧醇(V)和氧气在酸催化剂的作用下进行氧化重排反应得到青蒿素(VI)。(3) In a microchannel reactor, dihydroartemisinic anhydride (IV) and oxygen undergo a photooxidation reaction under the action of a photocatalyst to obtain the peroxyalcohol (V) of dihydroartemisinic anhydride; Peroxyalcohol (V) and oxygen undergo an oxidative rearrangement reaction under the action of an acid catalyst to obtain artemisinin (VI).
Figure PCTCN2020114150-appb-000004
Figure PCTCN2020114150-appb-000004
在优选的实施方案中,所述步骤(1)的反应温度为-10℃~40℃,优选0℃~30℃,更优选10℃~20℃。In a preferred embodiment, the reaction temperature in the step (1) is -10°C to 40°C, preferably 0°C to 30°C, more preferably 10°C to 20°C.
在优选的实施方案中,所述步骤(1)所用的反应溶剂为二氯甲烷、四氢呋喃、甲苯、己烷中的一种或几种的混合物。In a preferred embodiment, the reaction solvent used in the step (1) is one or a mixture of dichloromethane, tetrahydrofuran, toluene, and hexane.
在优选的实施方案中,所述步骤(1)所用的催化剂a为N,N-二甲基甲酰胺、四甲基脲及1,3二甲基咪唑啉酮中的至少一种。In a preferred embodiment, the catalyst a used in the step (1) is at least one of N,N-dimethylformamide, tetramethylurea and 1,3 dimethylimidazolinone.
在优选的实施方案中,所述步骤(1)中二氢青蒿酸(I)与催化剂a的摩尔比为1:0.001~1。In a preferred embodiment, the molar ratio of dihydroartemisinic acid (I) to catalyst a in the step (1) is 1:0.001 to 1.
在优选的实施方案中,所述步骤(1)中二氢青蒿酸(I)与草酰氯(II)的摩尔比为1:1.01~2。In a preferred embodiment, the molar ratio of dihydroartemisinic acid (I) to oxalyl chloride (II) in the step (1) is 1:1.01-2.
在优选的实施方案中,所述步骤(2)的反应温度为-10℃~20℃,优选-5℃~0℃。In a preferred embodiment, the reaction temperature in the step (2) is -10°C to 20°C, preferably -5°C to 0°C.
在优选的实施方案中,所述步骤(2)所用的反应溶剂为二氯甲烷、四氢呋喃、甲苯、己烷中的一种或几种。In a preferred embodiment, the reaction solvent used in the step (2) is one or more of dichloromethane, tetrahydrofuran, toluene, and hexane.
在优选的实施方案中,所述步骤(2)所用的催化剂b为缚酸剂,优选为三乙胺、吡啶、碳酸钾中的至少一种。In a preferred embodiment, the catalyst b used in the step (2) is an acid binding agent, preferably at least one of triethylamine, pyridine, and potassium carbonate.
在优选的实施方案中,所述步骤(2)中二氢青蒿酰氯(III)与二氢青蒿酸(I)的摩尔比为1:1.01~1.2。In a preferred embodiment, in the step (2), the molar ratio of dihydroartemisinyl chloride (III) to dihydroartemisinic acid (I) is 1:1.01 to 1.2.
在优选的实施方案中,所述步骤(3)中光氧化反应所用的有机溶剂为二氯甲烷、甲苯、乙腈、环己烷、正庚烷中的一种或几种。In a preferred embodiment, the organic solvent used in the photooxidation reaction in the step (3) is one or more of dichloromethane, toluene, acetonitrile, cyclohexane, and n-heptane.
在优选的实施方案中,所述步骤(3)中二氢青蒿酸酐(IV)与有机溶剂的质量体积比为1:2~20(单位是g/mL),优选1:4~6。In a preferred embodiment, the mass-volume ratio of dihydroartemisinic anhydride (IV) to the organic solvent in the step (3) is 1:2-20 (unit is g/mL), preferably 1:4-6.
在优选的实施方案中,所述步骤(3)中光催化剂为四苯基卟啉或其衍生物。In a preferred embodiment, the photocatalyst in the step (3) is tetraphenylporphyrin or a derivative thereof.
在优选的实施方案中,所述二氢青蒿酸酐(IV)与光催化剂的摩尔比为1:0.001~1,优选1:0.002~0.01。In a preferred embodiment, the molar ratio of the dihydroartemisinic anhydride (IV) to the photocatalyst is 1:0.001 to 1, preferably 1:0.002 to 0.01.
在优选的实施方案中,所述步骤(3)中酸催化剂为质子酸和或路易斯酸,优选三氟乙酸。In a preferred embodiment, the acid catalyst in the step (3) is a protic acid and or a Lewis acid, preferably trifluoroacetic acid.
在优选的实施方案中,所述步骤(3)中二氢青蒿酸酐(IV)与酸催化剂的摩尔比为1:0.3~2,优选1:0.5。In a preferred embodiment, the molar ratio of dihydroartemisinic anhydride (IV) to the acid catalyst in the step (3) is 1:0.3-2, preferably 1:0.5.
在优选的实施方案中,所述步骤(3)中光氧化反应所用的光源为LED光源。In a preferred embodiment, the light source used in the photooxidation reaction in the step (3) is an LED light source.
在优选的实施方案中,所述光源的波长为365~660nm,优选385nm或405nm,更优选385nm。In a preferred embodiment, the wavelength of the light source is 365-660 nm, preferably 385 nm or 405 nm, more preferably 385 nm.
在优选的实施方案中,所述步骤(3)中光氧化反应的反应温度为-10℃~20℃,优选为-5℃~5℃,更优选为0℃。In a preferred embodiment, the reaction temperature of the photooxidation reaction in the step (3) is -10°C to 20°C, preferably -5°C to 5°C, more preferably 0°C.
在优选的实施方案中,所述步骤(3)中氧化重排反应的反应温度为5℃~60℃,优选为20℃。In a preferred embodiment, the reaction temperature of the oxidative rearrangement reaction in the step (3) is 5°C-60°C, preferably 20°C.
在优选的实施方案中,所述步骤(3)中光氧化反应的停留时间为2.9min~10.2min,优选4min~5.5min;所述步骤(3)中氧化重排反应的停留时间为1.7min~5.7min。In a preferred embodiment, the residence time of the photooxidation reaction in the step (3) is 2.9 min to 10.2 min, preferably 4 min to 5.5 min; the residence time of the oxidation rearrangement reaction in the step (3) is 1.7 min ~5.7min.
在优选的实施方案中,所述步骤(3)在微通道反应器中氧气的流速为120ml/min~300ml/min,优选160ml/min~240ml/min。In a preferred embodiment, the flow rate of oxygen in the microchannel reactor in the step (3) is 120 ml/min to 300 ml/min, preferably 160 ml/min to 240 ml/min.
在优选的实施方案中,所述步骤(3)的光氧化反应与氧化重排反应为连续式反应,光氧化反应与氧化重排反应压力均为0.5~1.7MPa。In a preferred embodiment, the photooxidation reaction and the oxidation rearrangement reaction in the step (3) are continuous reactions, and the pressure of the photooxidation reaction and the oxidation rearrangement reaction are both 0.5-1.7 MPa.
在优选的实施方案中,所述微通道反应器,包括温控仪1、玻璃微通道模块2、碳化硅微通道模块3、光源4、氧源5、进料泵7和8、背压阀9;其中,In a preferred embodiment, the microchannel reactor includes a temperature controller 1, a glass microchannel module 2, a silicon carbide microchannel module 3, a light source 4, an oxygen source 5, feed pumps 7 and 8, and a back pressure valve 9; Among them,
所述温控仪1为双温区的温度控制器;The temperature controller 1 is a temperature controller with dual temperature zones;
所述玻璃微通道模块2由玻璃材质制作,为薄板方形,内部具有心型结构的混合装置;The glass microchannel module 2 is made of glass material, is a thin plate square, and has a mixing device with a heart-shaped structure inside;
所述碳化硅微通道模块3由碳化硅材质制作,为薄板方形,内部具有心型结构的混合装置;The silicon carbide microchannel module 3 is made of silicon carbide, is a thin plate square, and has a mixing device with a heart-shaped structure inside;
所述进料泵7和8为能承受高压的泵,优选KP-22或汉邦;The feed pumps 7 and 8 are pumps that can withstand high pressure, preferably KP-22 or Hanbang;
所述背压阀9具有反压调节功能。The back pressure valve 9 has a back pressure adjustment function.
在优选的实施方案中,所述步骤3)还包括对制得的青蒿素进一步结晶提纯,所用的结晶溶剂为甲醇、乙醇、异丙醇、丙酮、甲醇和水、乙醇和水中的一种或几种,优选乙醇。In a preferred embodiment, the step 3) also includes further crystallization and purification of the prepared artemisinin, and the crystallization solvent used is one of methanol, ethanol, isopropanol, acetone, methanol and water, ethanol and water Or several, preferably ethanol.
本发明所述的二氢青蒿酸酐转化为青蒿素的过程在微通道反应器中进行的反应过程如下:A)单线态氧光化学诱导氧化二氢青蒿酸酐;B)以三氟乙酸进行水解和Hock裂解;C)用三线态氧进行氧化反应生成青蒿素。The process of converting dihydroartemisinic anhydride into artemisinin of the present invention is carried out in a microchannel reactor as follows: A) singlet oxygen photochemically induces oxidation of dihydroartemisinic anhydride; B) using trifluoroacetic acid Hydrolysis and Hock cracking; C) The oxidation reaction with triplet oxygen produces artemisinin.
本发明所述的连续式是指从微通道反应器原料的入口到出口,含有二氢青蒿酸酐的混合溶液不停地流动,可以连续不断的发生反应,至少在光氧化反应中二氢青蒿酸酐是可以连续不断的被转化为二氢青蒿酸酐的过氧醇。在设定好原料流量、氧气流量、三氟乙酸流量等相关参数情况下,反应可以持续的发生转化,微通道反应器出口可以连续不断的有产物生成。当但并非是指在微通道反应器中发生的两次氧化反应是不可以中停的,调整光源、氧气用尽等时,反应就是停止的。The continuous type described in the present invention means that the mixed solution containing dihydroartemisinic anhydride flows continuously from the inlet to the outlet of the raw material of the microchannel reactor, and can react continuously, at least in the photooxidation reaction. Artemisinic anhydride is a peroxyalcohol that can be continuously converted to dihydroartemisinic anhydride. Under the condition that the raw material flow rate, oxygen flow rate, trifluoroacetic acid flow rate and other related parameters are set, the reaction can be continuously transformed, and the outlet of the microchannel reactor can continuously produce products. But it does not mean that the two oxidation reactions occurring in the microchannel reactor cannot be stopped. The reaction is stopped when the light source is adjusted and the oxygen is exhausted.
本发明微通道反应器内进行的光氧化反应和氧化重排反应需要在压力下进行,氧气罐内的纯氧在输入时,能促进微通道反应器中料液的推进,给连续进行的反应提供一定的动力。此外,微通道反应器设备本身也带有背压阀(加压装置),压力对于光氧化反应的效率极为重要,很大程度上影响着二氢青蒿酸酐的转化效率。The photooxidation reaction and the oxidation rearrangement reaction carried out in the microchannel reactor of the present invention need to be carried out under pressure. When the pure oxygen in the oxygen tank is input, it can promote the advancement of the material liquid in the microchannel reactor, and give a continuous reaction. Provide a certain amount of motivation. In addition, the microchannel reactor equipment itself also has a back pressure valve (pressurization device). Pressure is extremely important for the efficiency of the photooxidation reaction, and it greatly affects the conversion efficiency of dihydroartemisinic anhydride.
按照本发明方法制得的青蒿素收率高,纯度好,纯度可高达99.5%,此外,利用本发明方法使用一台微通道反应器年通量中试级别为3.5吨/年,生产型可达42吨/年(一年按300天计算),通量高,转化率高,反应液混合效果好,工艺稳定,可用于批量生产。The artemisinin prepared according to the method of the present invention has high yield, good purity, and the purity can be as high as 99.5%. In addition, the annual throughput of a microchannel reactor using the method of the present invention is 3.5 tons per year. Up to 42 tons/year (calculated as 300 days a year), high throughput, high conversion rate, good reaction liquid mixing effect, stable process, and can be used for mass production.
相较于现有技术,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
1.本发明所述工艺制备的青蒿素成品收率高、纯度好,纯度可达99.5%。1. The artemisinin product prepared by the process of the present invention has high yield and good purity, and the purity can reach 99.5%.
2.本发明所述工艺中使用的微通道反应器,通量高,转化率高,反应液混合效果好,工艺安全稳定可用于批量生产。同时,本发明微通道反应中进行的光氧化反应以及氧化重排反 应反应时间短,而且本发明微通道反应器可同时进行光氧化反应以及氧化重排反应,进一步缩短反应时间。2. The microchannel reactor used in the process of the present invention has high flux, high conversion rate, good reaction liquid mixing effect, safe and stable process, and can be used for mass production. At the same time, the photooxidation reaction and the oxidation rearrangement reaction in the microchannel reaction of the present invention have a short reaction time, and the microchannel reactor of the present invention can simultaneously perform the photooxidation reaction and the oxidation rearrangement reaction, further shortening the reaction time.
3.相较于现有技术披露的微通道反应反应温度低至-50℃,本发明反应条件温和。3. Compared with the reaction temperature of the microchannel disclosed in the prior art as low as -50°C, the reaction conditions of the present invention are mild.
4.本发明起始物料为二氢青蒿酸酐,相较于二氢青蒿酸,对羧酸进行了保护,抑制了脱羧副反应,而且二氢青蒿酸酐可以在有机溶剂中增加溶解性,使溶液比较均匀,从而透光也较均匀,有利于光氧化反应。4. The starting material of the present invention is dihydroartemisinic anhydride. Compared with dihydroartemisinic acid, the carboxylic acid is protected and the side reaction of decarboxylation is inhibited. Dihydroartemisinic anhydride can increase the solubility in organic solvents. , So that the solution is more uniform, so that the light transmission is also more uniform, which is conducive to the photo-oxidation reaction.
附图说明Description of the drawings
图1为本发明所述微通道反应器结构示意图。Figure 1 is a schematic diagram of the structure of the microchannel reactor of the present invention.
具体实施方式detailed description
下面将对本发明实施例中的技术方案进行清楚、完整的描述。显然,所描述的实施例仅仅是本发明的一部分实施例,而不是全部的实施例。基于本发明的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be described clearly and completely below. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative work shall fall within the protection scope of the present invention.
本发明所使用的试剂和溶剂没有特别的限制,可采用商购的常规溶剂。应当强调的是,本发明技术方案中所涉及的数值或数值端点,其含义或意义的保护范围并不局限于该数字本身,本领域技术人员能够理解,它们包含了那些已被本领域广为接受的可允许误差范围,例如实验误差、测量误差、统计误差和随机误差等等,而这些误差范围均包含在本发明的范围之内。The reagents and solvents used in the present invention are not particularly limited, and commercially available conventional solvents can be used. It should be emphasized that the meaning or protection scope of the numerical value or numerical endpoint involved in the technical solution of the present invention is not limited to the number itself. Those skilled in the art can understand that they include those that have been widely used in the art. Acceptable allowable error ranges, such as experimental errors, measurement errors, statistical errors and random errors, etc., and these error ranges are all included in the scope of the present invention.
本发明中所涉及的青蒿素的纯度均是通过高效液相色谱(HPLC)检测的,仪器及色谱条件如下:液相色谱仪型号为Agilent 1100series,色谱柱为CAPCELL PAK C18 TYPE MGII,4.6mm×250mm,5μm;流动相为乙腈:水=50:50(V:V);流速为1ml/min;紫外检测波长为210nm;进样量为20μL。纯度指在HPLC图谱中目标物的色谱峰面积占总峰面积的百分比。比如,青蒿素纯度指样品HPLC图谱中青蒿素的峰面积所占的百分比。The purity of the artemisinin involved in the present invention is detected by high performance liquid chromatography (HPLC). The instrument and chromatographic conditions are as follows: the model of the liquid chromatograph is Agilent 1100series, and the chromatographic column is CAPCELL PAK C18 TYPE MGII, 4.6mm ×250mm, 5μm; mobile phase is acetonitrile: water=50:50(V:V); flow rate is 1ml/min; UV detection wavelength is 210nm; sample volume is 20μL. Purity refers to the percentage of the chromatographic peak area of the target in the HPLC spectrum to the total peak area. For example, the purity of artemisinin refers to the percentage of the peak area of artemisinin in the HPLC spectrum of the sample.
二氢青蒿酸可以是市售,也可以是合成,本实施例所使用的二氢青蒿酸是由青蒿酸通过还原反应制备的。Dihydroartemisinic acid can be commercially available or synthesized. The dihydroartemisinic acid used in this example is prepared from artemisinic acid through a reduction reaction.
反应设备实施例Examples of reaction equipment
参照图1,本发明微通道反应器包括一个双温区控制的温控仪1、五块玻璃微通道模块2、三块碳化硅微通道模块3、光源4、一个氧源5、一个气体流量计6、两台进料泵7和8,一个背压阀9、两个配料罐10和11、一个接收罐12。其中:光源4在每块玻璃微通道模块2的两侧同时照射,增加了光的光透率,如图1中箭头所示;玻璃微通道模块2由玻璃材质制作,为薄板方形,内部具有心型结构的混合装置,增加了反应的混合效果;碳化硅微 通道模块3由碳化硅材质制作,为薄板方形,内部具有心型结构的混合装置,增加了反应的混合效果;温控仪1连接的冷却液紧贴玻璃微通道模块2和碳化硅微通道模块3,增强了反应的换热效率。1, the microchannel reactor of the present invention includes a temperature controller with dual temperature zone control 1, five glass microchannel modules 2, three silicon carbide microchannel modules 3, a light source 4, an oxygen source 5, and a gas flow Count 6, two feed pumps 7 and 8, a back pressure valve 9, two batching tanks 10 and 11, and a receiving tank 12. Among them: the light source 4 irradiates both sides of each glass microchannel module 2 at the same time, which increases the light transmittance of light, as shown by the arrow in Fig. 1; the glass microchannel module 2 is made of glass material and has a thin plate square shape inside. The mixing device with a heart-shaped structure increases the mixing effect of the reaction; the silicon carbide microchannel module 3 is made of silicon carbide and is a thin plate square with a mixing device with a heart-shaped structure inside, which increases the mixing effect of the reaction; temperature controller 1 The connected cooling liquid closely adheres to the glass microchannel module 2 and the silicon carbide microchannel module 3, which enhances the heat exchange efficiency of the reaction.
温控仪1具有冷却或加热功能;The temperature controller 1 has a cooling or heating function;
玻璃微通道模块2和碳化硅微通道模块3分别和双温区的温控仪1相连;The glass microchannel module 2 and the silicon carbide microchannel module 3 are respectively connected to the temperature controller 1 in the dual temperature zone;
反应液在玻璃微通道模块2和碳化硅微通道模块3中连续流动;The reaction liquid flows continuously in the glass microchannel module 2 and the silicon carbide microchannel module 3;
光源4为LED光源;The light source 4 is an LED light source;
氧源5为氧气;The oxygen source 5 is oxygen;
气体流量计6用于调节气体流速;The gas flow meter 6 is used to adjust the gas flow rate;
进料泵7用于光氧化反应进料及提供连续流动力;The feed pump 7 is used to feed the photo-oxidation reaction and provide continuous flow force;
进料泵8用于氧化重排反应进料及提供动力;The feed pump 8 is used to feed the oxidation rearrangement reaction and provide power;
背压阀9用于调节压力;The back pressure valve 9 is used to adjust the pressure;
配料罐10用于储存二氢青蒿酸酐溶液,配料罐11用于储存酸催化剂,例如三氟乙酸;The batching tank 10 is used to store dihydroartemisinic anhydride solution, and the batching tank 11 is used to store acid catalysts, such as trifluoroacetic acid;
接收罐12用于接收反应液。The receiving tank 12 is used to receive the reaction liquid.
制备例 二氢青蒿酸的制备Preparation Example Preparation of dihydroartemisinic acid
向1000g(4.2675mol)青蒿酸中加入3000ml无水乙醇和2000ml(35.02mol)85%水合肼,控温-10℃滴加1800ml(17.6294mol)30%双氧水,4H后反应结束,滴加6N的盐酸水溶液至PH=1得二氢青蒿酸996.6g(4.2170mol),收率98.74%。Add 3000ml absolute ethanol and 2000ml (35.02mol) 85% hydrazine hydrate to 1000g (4.2675mol) artemisinic acid, add 1800ml (17.6294mol) 30% hydrogen peroxide dropwise at -10℃, the reaction is over after 4H, and 6N is added dropwise The hydrochloric acid aqueous solution to pH=1 to obtain 996.6 g (4.2170 mol) of dihydroartemisinic acid, with a yield of 98.74%.
实施例1:青蒿素的制备Example 1: Preparation of artemisinin
将制备例制得的二氢青蒿酸50g(0.2116mol)加入到250ml二氯甲烷中,加入N,N-二甲基甲酰胺2.5ml(0.03247mol),在10℃下滴加21.67ml(0.2543mol)草酰氯,1小时后反应完毕,将反应液浓缩干后得二氢青蒿酰氯53.2g(0.2094mol),再加入250ml二氯甲烷,20ml三乙胺,控温0℃下加入二氢青蒿酸50g(0.2116mol),2小时后反应完毕,浓缩得二氢青蒿酸酐94.11g(0.2073mol),收率97.97%。Add 50g (0.2116mol) of dihydroartemisinic acid prepared in the preparation example to 250ml of dichloromethane, add 2.5ml (0.03247mol) of N,N-dimethylformamide, and add 21.67ml( 0.2543mol) oxalyl chloride. After 1 hour, the reaction was completed. After the reaction solution was concentrated to dryness, 53.2g (0.2094mol) of dihydroartemisinyl chloride was obtained. Then 250ml of dichloromethane and 20ml of triethylamine were added. Hydroartemisinic acid 50g (0.2116mol), after 2 hours, the reaction was completed, concentrated to obtain dihydroartemisinic anhydride 94.11g (0.2073mol), the yield was 97.97%.
将二氢青蒿酸酐94.11g(0.2073mol),0.3g四苯基卟啉(0.00049mol),加入560ml二氯甲烷溶清后得料液。设置温控仪1中连接玻璃微通道模块2的温度为-5℃,温控仪1中连接碳化硅微通道模块3的温度为5℃,打开光源4,设定波长为405nm,开氧源5,设定氧气流速为240ml/min,用氧气调节背压阀9至1.6MPa,用进料泵7向玻璃微通道模块2中以14ml/min的流速打入上述料液,停留时间2.9分钟后光氧化反应结束得反应液,反应液进入碳化硅微通道模块3,开进料泵8,以0.3ml/min的流速打入三氟乙酸,进行氧化重排反应, 停留时间1.7min后得青蒿素粗品溶液590ml,接收完毕后关闭氧源5、光源4、进料泵7和8、温控仪1。94.11 g (0.2073 mol) of dihydroartemisinic anhydride and 0.3 g of tetraphenylporphyrin (0.00049 mol) were added to 560 ml of dichloromethane to dissolve the solution to obtain a liquid. Set the temperature of the glass microchannel module 2 connected to the thermostat 1 to -5℃, and the temperature of the silicon carbide microchannel module 3 connected to the thermostat 1 to 5℃, turn on the light source 4, set the wavelength to 405nm, and turn on the oxygen source 5. Set the oxygen flow rate to 240ml/min, use oxygen to adjust the back pressure valve 9 to 1.6MPa, and use the feed pump 7 to drive the above-mentioned liquid into the glass microchannel module 2 at a flow rate of 14ml/min, the residence time is 2.9 minutes After the photooxidation reaction is completed, the reaction solution is obtained. The reaction solution enters the silicon carbide microchannel module 3, the feed pump 8 is turned on, and trifluoroacetic acid is injected at a flow rate of 0.3ml/min to carry out the oxidation rearrangement reaction. The residence time is 1.7min. The crude artemisinin solution is 590ml, and the oxygen source 5, light source 4, feed pumps 7 and 8, and temperature controller 1 are turned off after receiving.
向青蒿素粗品溶液加80ml饱和碳酸氢钠水溶液,分层,弃去水层,有机相30℃下减压浓缩至干,加入500ml 90%的乙醇水溶液结晶,得青蒿素(VI)85g(0.3011mol),收率72.62%(以二氢青蒿酸酐计算),经HPLC检测,式VI化合物纯度为99.5%,总收率为71.14%(以二氢青蒿酸计算)。Add 80ml of saturated sodium bicarbonate aqueous solution to the crude artemisinin solution, separate the layers, discard the aqueous layer, and concentrate the organic phase to dryness under reduced pressure at 30°C. Add 500ml 90% ethanol aqueous solution to crystallize to obtain artemisinin (VI) 85g (0.3011mol), the yield is 72.62% (calculated by dihydroartemisinic anhydride), the purity of the compound of formula VI is 99.5% by HPLC detection, and the total yield is 71.14% (calculated by dihydroartemisinic acid).
实施例2:青蒿素的制备Example 2: Preparation of artemisinin
将制备例制得的二氢青蒿酸50g(0.2116mol)加入到250ml二氯甲烷中,加入N,N-二甲基甲酰胺2.5ml(0.03247mol),在10℃下滴加21.67ml(0.2543mol)草酰氯,1小时后反应完毕,将反应液浓缩干后得二氢青蒿酰氯52.8g(0.2079mol),再加入250ml二氯甲烷,20ml三乙胺,控温-5℃下加入二氢青蒿酸50g(0.2116mol),2小时后反应完毕,浓缩得二氢青蒿酸酐93.1g(0.2051mol),收率96.93%。Add 50g (0.2116mol) of dihydroartemisinic acid prepared in the preparation example to 250ml of dichloromethane, add 2.5ml (0.03247mol) of N,N-dimethylformamide, and add 21.67ml( 0.2543mol) oxalyl chloride. After 1 hour, the reaction is complete. After the reaction solution is concentrated to dryness, 52.8g (0.2079mol) of dihydroartemisinyl chloride is obtained. Then 250ml of dichloromethane and 20ml of triethylamine are added, and the temperature is controlled at -5°C. Dihydroartemisinic acid 50g (0.2116mol), the reaction was completed after 2 hours, concentrated to obtain dihydroartemisinic anhydride 93.1g (0.2051mol), the yield was 96.93%.
将二氢青蒿酸酐93.1g(0.2051mol),1.3g四苯基卟啉(0.002117mol),加入370ml甲苯溶清后得料液。设置温控仪1中连接玻璃微通道模块2的温度为0℃,温控仪1中连接碳化硅微通道模块3的温度为20℃,打开光源4,设定波长为385nm,开氧源5,设定氧气流速为200ml/min,用氧气调节背压阀9至1MPa,用进料泵7向玻璃微通道模块2中以9ml/min的流速打入上述料液,停留时间4.6分钟后,光氧化反应结束得反应液,反应液进入碳化硅反应器模块3,开进料泵8,以0.3ml/min的流速打入三氟乙酸,进行氧化重排反应,停留时间2.7min后得青蒿素粗品溶液400ml,接收完毕后关闭氧源5、光源4、进料泵7和8、温控仪1.93.1 g (0.2051 mol) of dihydroartemisinic anhydride and 1.3 g of tetraphenylporphyrin (0.002117 mol) were added to 370 ml of toluene to dissolve to obtain a liquid. Set the temperature of the glass microchannel module 2 connected to the thermostat 1 to 0℃, and the temperature of the silicon carbide microchannel module 3 connected to the thermostat 1 to 20℃, turn on the light source 4, set the wavelength to 385nm, and turn on the oxygen source 5. , Set the oxygen flow rate to 200ml/min, use oxygen to adjust the back pressure valve 9 to 1MPa, and use the feed pump 7 to drive the above-mentioned liquid into the glass microchannel module 2 at a flow rate of 9ml/min. After a residence time of 4.6 minutes, After the photooxidation reaction is completed, the reaction solution is obtained. The reaction solution enters the silicon carbide reactor module 3, the feed pump 8 is turned on, and trifluoroacetic acid is injected at a flow rate of 0.3ml/min to carry out the oxidation rearrangement reaction. 400ml of crude artemisinin solution. After receiving, turn off the oxygen source 5, light source 4, feed pumps 7 and 8, temperature controller 1.
向青蒿素粗品溶液加80ml饱和碳酸氢钠溶液,分层,弃去水层,有机相50℃下减压浓缩至干,加入500ml 90%的乙醇水溶液结晶,得青蒿素(VI)88g(0.3117mol),收率75.99%(以二氢青蒿酸酐计算)。经HPLC检测,式VI化合物纯度为99.4%,总收率为73.65%(以二氢青蒿酸计算)。Add 80ml of saturated sodium bicarbonate solution to the crude artemisinin solution, separate the layers, discard the aqueous layer, and concentrate the organic phase to dryness under reduced pressure at 50°C. Add 500ml 90% ethanol aqueous solution to crystallize to obtain artemisinin (VI) 88g (0.3117mol), the yield is 75.99% (calculated based on dihydroartemisinic anhydride). Detected by HPLC, the purity of the compound of formula VI is 99.4%, and the total yield is 73.65% (calculated based on dihydroartemisinic acid).
实施例3:青蒿素的制备Example 3: Preparation of artemisinin
将制备例制得的二氢青蒿酸50g(0.2116mol)加入到250ml二氯甲烷中,加入N,N-二甲基甲酰胺2.5ml(0.03247mol),在10℃下滴加21.67ml(0.2543mol)草酰氯,1小时后反应完毕,将反应液浓缩干后得二氢青蒿酰氯52.8g(0.2079mol),再加入250ml二氯甲烷, 20ml三乙胺,控温0℃下加入二氢青蒿酸50g(0.2116mol),2小时后反应完毕,浓缩得二氢青蒿酸酐92.8g(0.2041mol),收率96.60%。Add 50g (0.2116mol) of dihydroartemisinic acid prepared in the preparation example to 250ml of dichloromethane, add 2.5ml (0.03247mol) of N,N-dimethylformamide, and add 21.67ml( 0.2543mol) oxalyl chloride. After 1 hour, the reaction was completed. After the reaction solution was concentrated to dryness, 52.8g (0.2079mol) of dihydroartemisinyl chloride was obtained. Then 250ml of dichloromethane and 20ml of triethylamine were added. Hydroartemisinic acid 50g (0.2116mol), the reaction was completed after 2 hours, concentrated to obtain dihydroartemisinic anhydride 92.8g (0.2041mol), the yield was 96.60%.
将二氢青蒿酸酐92.8g(0.2041mol),0.3g四苯基卟啉(0.00049mol),加入500ml甲苯溶清后得料液。设置温控仪1中连接玻璃微通道模块2的温度为-5℃,温控仪1中连接碳化硅微通道模块3的温度为50℃,打开光源4,设定波长为405nm,开氧源5,设定氧气流速为200ml/min,用氧气调节背压阀9至0.6MPa,用进料泵7向玻璃微通道模块2中以4.2ml/min的流速打入上述料液,停留时间9.8分钟后光氧化反应结束得反应液,反应液进入碳化硅微通道模块3,开进料泵8,以0.2ml/min的流速打入三氟乙酸,进行氧化重排反应,停留时间5.7min后得青蒿素粗品溶液520ml,接收完毕后关闭氧源5、光源4、进料泵7和8、温控仪1.Add 92.8 g (0.2041 mol) of dihydroartemisinic anhydride and 0.3 g of tetraphenylporphyrin (0.00049 mol) to 500 ml of toluene to obtain a liquid. Set the temperature of the glass microchannel module 2 connected to the thermostat 1 to -5℃, and the temperature of the silicon carbide microchannel module 3 connected to the thermostat 1 to 50℃, turn on the light source 4, set the wavelength to 405nm, and turn on the oxygen source 5. Set the oxygen flow rate to 200ml/min, use oxygen to adjust the back pressure valve 9 to 0.6MPa, and use the feed pump 7 to inject the above-mentioned material into the glass microchannel module 2 at a flow rate of 4.2ml/min, with a residence time of 9.8 Minutes later, the photooxidation reaction is completed to obtain the reaction solution, the reaction solution enters the silicon carbide microchannel module 3, the feed pump 8 is turned on, and trifluoroacetic acid is injected at a flow rate of 0.2ml/min to carry out the oxidation rearrangement reaction. The residence time is 5.7min. Obtain 520ml of the crude artemisinin solution. After receiving, turn off the oxygen source 5, light source 4, feed pumps 7 and 8, and temperature controller 1.
向青蒿素粗品溶液加80ml饱和碳酸氢钠水溶液,分层,弃去水层,有机相30℃下减压浓缩至干,加入400ml乙醇结晶,得青蒿素(VI)86g(0.3046mol),收率74.62%(以二氢青蒿酸酐计算),经HPLC检测,式VI化合物纯度为99.3%,总收率为72.08%(以二氢青蒿酸计算)。Add 80ml of saturated aqueous sodium bicarbonate solution to the crude artemisinin solution, separate the layers, discard the aqueous layer, and concentrate the organic phase to dryness under reduced pressure at 30°C. Add 400ml of ethanol to crystallize to obtain 86g (0.3046mol) of artemisinin (VI) The yield is 74.62% (calculated by dihydroartemisinic anhydride), the purity of the compound of formula VI is 99.3% by HPLC detection, and the total yield is 72.08% (calculated by dihydroartemisinic acid).

Claims (9)

  1. 一种青蒿素(VI)的化学半合成方法,其特征在于,包括以下步骤:A chemical semi-synthetic method of artemisinin (VI), which is characterized in that it comprises the following steps:
    (1)二氢青蒿酸(I)与草酰氯(II)反应,生成二氢青蒿酰氯(III);(1) Dihydroartemisinic acid (I) reacts with oxalyl chloride (II) to produce dihydroartemisinyl chloride (III);
    Figure PCTCN2020114150-appb-100001
    Figure PCTCN2020114150-appb-100001
    (2)二氢青蒿酰氯(III)与二氢青蒿酸(I)进行酰化反应,生成二氢青蒿酸酐(IV);(2) Dihydroartemisinic acid (III) and dihydroartemisinic acid (I) undergo an acylation reaction to generate dihydroartemisinic anhydride (IV);
    Figure PCTCN2020114150-appb-100002
    Figure PCTCN2020114150-appb-100002
    (3)在微通道反应器中,二氢青蒿酸酐(IV)和氧气在光催化剂的作用下进行光氧化反应得到二氢青蒿酸酐的过氧醇(V);二氢青蒿酸酐的过氧醇(V)和氧气在酸催化剂的作用下进行氧化重排反应得到青蒿素(VI)。(3) In a microchannel reactor, dihydroartemisinic anhydride (IV) and oxygen undergo a photooxidation reaction under the action of a photocatalyst to obtain the peroxyalcohol (V) of dihydroartemisinic anhydride; Peroxyalcohol (V) and oxygen undergo an oxidative rearrangement reaction under the action of an acid catalyst to obtain artemisinin (VI).
    Figure PCTCN2020114150-appb-100003
    Figure PCTCN2020114150-appb-100003
  2. 根据权利要求1所述的方法,其特征在于,所述步骤(3)中光氧化反应所用的有机溶剂为二氯甲烷、甲苯、乙腈、环己烷、正庚烷中的一种或几种,所述二氢青蒿酸酐(IV)与有机溶剂的质量体积比为1:2~20(单位是g/mL),优选1:4~6。The method according to claim 1, wherein the organic solvent used in the photooxidation reaction in the step (3) is one or more of dichloromethane, toluene, acetonitrile, cyclohexane, and n-heptane The mass-volume ratio of the dihydroartemisinic anhydride (IV) to the organic solvent is 1:2-20 (unit is g/mL), preferably 1:4-6.
  3. 根据权利要求1或2所述的方法,其特征在于,所述步骤(3)中光催化剂为四苯基卟啉或其衍生物,二氢青蒿酸酐(IV)与光催化剂的摩尔比为1:0.001~1,优选1:0.002~0.01;所述酸催化剂为质子酸和或路易斯酸,优选三氟乙酸。The method according to claim 1 or 2, wherein the photocatalyst in the step (3) is tetraphenylporphyrin or a derivative thereof, and the molar ratio of dihydroartemisinic anhydride (IV) to the photocatalyst is 1: 0.001 to 1, preferably 1: 0.002 to 0.01; the acid catalyst is a protic acid and or a Lewis acid, preferably trifluoroacetic acid.
  4. 根据权利要求1-3任一项所述的方法,其特征在于,所述步骤(3)中光氧化反应所用的光源为LED光源,所述光源的波长为365-660nm,优选385nm或405nm,更优选385nm。The method according to any one of claims 1 to 3, wherein the light source used in the photooxidation reaction in the step (3) is an LED light source, and the wavelength of the light source is 365-660nm, preferably 385nm or 405nm, It is more preferably 385 nm.
  5. 根据权利要求1-4任一项所述的方法,其特征在于,所述步骤(3)中光氧化反应的反应温度为-10℃~20℃,优选为-5℃~5℃,更优选为0℃;所述步骤(3)中氧化重排反应的反应温度为5℃~60℃,优选为20℃;所述步骤(3)中光氧化反应的停留时间2.9min~10.2min,优选4min~5.5min;所述步骤(3)中氧化重排反应的停留时间为1.7min~5.7min。The method according to any one of claims 1 to 4, wherein the reaction temperature of the photooxidation reaction in the step (3) is -10°C to 20°C, preferably -5°C to 5°C, more preferably The reaction temperature of the oxidative rearrangement reaction in the step (3) is 5°C to 60°C, preferably 20°C; the residence time of the photooxidation reaction in the step (3) is 2.9 min to 10.2 min, preferably 4min~5.5min; the residence time of the oxidation rearrangement reaction in the step (3) is 1.7min~5.7min.
  6. 根据权利要求1-5任一项所述的方法,其特征在于,所述步骤(3)在微通道反应器中氧气的流速为120ml/min~300ml/min,优选160ml/min~240ml/min。The method according to any one of claims 1-5, wherein the flow rate of oxygen in the microchannel reactor in the step (3) is 120ml/min~300ml/min, preferably 160ml/min~240ml/min .
  7. 根据权利要求1-6任一项所述的方法,其特征在于,所述步骤(3)的光氧化反应与氧化重排反应为连续式反应,光氧化反应与氧化重排反应压力均为0.5-1.7MPa。The method according to any one of claims 1-6, wherein the photooxidation reaction and the oxidation rearrangement reaction in the step (3) are continuous reactions, and the pressure of the photooxidation reaction and the oxidation rearrangement reaction are both 0.5 -1.7MPa.
  8. 根据权利要求1-7任一项所述的方法,其特征在于,所述微通道反应器,包括温控仪1、玻璃微通道模块2、碳化硅微通道模块3、光源4、氧源5、进料泵7和8、背压阀9;其中,The method according to any one of claims 1-7, wherein the microchannel reactor comprises a temperature controller 1, a glass microchannel module 2, a silicon carbide microchannel module 3, a light source 4, and an oxygen source 5. , Feed pumps 7 and 8, back pressure valve 9; among them,
    所述温控仪1为双温区的温度控制器;The temperature controller 1 is a temperature controller with dual temperature zones;
    所述玻璃微通道模块2由玻璃材质制作,为薄板方形,内部具有心型结构的混合装置;The glass microchannel module 2 is made of glass material, is a thin plate square, and has a mixing device with a heart-shaped structure inside;
    所述碳化硅微通道模块3由碳化硅材质制作,为薄板方形,内部具有心型结构的混合装置;The silicon carbide microchannel module 3 is made of silicon carbide, is a thin plate square, and has a mixing device with a heart-shaped structure inside;
    所述进料泵7和8为能承受高压的泵,优选KP-22或汉邦泵;The feed pumps 7 and 8 are pumps that can withstand high pressure, preferably KP-22 or Hanbang pumps;
    所述背压阀9具有反压调节功能。The back pressure valve 9 has a back pressure adjustment function.
  9. 根据权利要求1-8任一项所述的方法,其特征在于,所述步骤3)还包括对制得的青蒿素进一步结晶提纯,所用的结晶溶剂为甲醇、乙醇、异丙醇、丙酮、甲醇和水、乙醇和水中的一种或几种,优选乙醇。The method according to any one of claims 1-8, wherein the step 3) further comprises further crystallization and purification of the prepared artemisinin, and the crystallization solvent used is methanol, ethanol, isopropanol, acetone One or more of, methanol and water, ethanol and water, preferably ethanol.
PCT/CN2020/114150 2019-09-18 2020-09-09 Chemical semi-synthesis method for artemisinin WO2021052225A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910880764.7 2019-09-18
CN201910880764.7A CN110590802B (en) 2019-09-18 2019-09-18 Chemical semi-synthesis method of artemisinin

Publications (1)

Publication Number Publication Date
WO2021052225A1 true WO2021052225A1 (en) 2021-03-25

Family

ID=68860526

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/114150 WO2021052225A1 (en) 2019-09-18 2020-09-09 Chemical semi-synthesis method for artemisinin

Country Status (2)

Country Link
CN (1) CN110590802B (en)
WO (1) WO2021052225A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110590802B (en) * 2019-09-18 2021-02-02 浙江海正药业股份有限公司 Chemical semi-synthesis method of artemisinin

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009088404A1 (en) * 2007-12-30 2009-07-16 Amyris Biotechnologies, Inc. Processes for the preparation of artemisinin an its precursors
CN102596967A (en) * 2009-09-01 2012-07-18 赛诺菲 Photochemical process for producing artemisinin
CN102718773A (en) * 2012-06-05 2012-10-10 上海交通大学 Method for preparing artemisinin through arteannuic acid
CN103739609A (en) * 2013-11-28 2014-04-23 湖南科源生物制品有限公司 Method and equipment for scale production of artemisinin
CN103764660A (en) * 2011-08-29 2014-04-30 马普科技促进协会 Method and device for the synthesis of artemisinin
CN110590802A (en) * 2019-09-18 2019-12-20 浙江海正药业股份有限公司 Chemical semi-synthesis method of artemisinin

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009088404A1 (en) * 2007-12-30 2009-07-16 Amyris Biotechnologies, Inc. Processes for the preparation of artemisinin an its precursors
CN102596967A (en) * 2009-09-01 2012-07-18 赛诺菲 Photochemical process for producing artemisinin
CN103764660A (en) * 2011-08-29 2014-04-30 马普科技促进协会 Method and device for the synthesis of artemisinin
CN102718773A (en) * 2012-06-05 2012-10-10 上海交通大学 Method for preparing artemisinin through arteannuic acid
CN103739609A (en) * 2013-11-28 2014-04-23 湖南科源生物制品有限公司 Method and equipment for scale production of artemisinin
CN110590802A (en) * 2019-09-18 2019-12-20 浙江海正药业股份有限公司 Chemical semi-synthesis method of artemisinin

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DANIEL KOPETZKI, FRANÇOIS LÉVESQUE, PETER H. SEEBERGER: "A Continuous-Flow Process for the Synthesis of Artemisinin", CHEMISTRY - A EUROPEAN JOURNAL, VERLAG CHEMIE| :, vol. 19, no. 17, 22 April 2013 (2013-04-22), pages 5450 - 5456, XP055067295, ISSN: 09476539, DOI: 10.1002/chem.201204558 *
LÉVESQUE FRANÇOIS, SEEBERGER PETER H.: "Continuous-Flow Synthesis of the Anti-Malaria Drug Artemisinin", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, VERLAG CHEMIE, vol. 51, no. 7, 13 February 2012 (2012-02-13), pages 1706 - 1709, XP055795355, ISSN: 1433-7851, DOI: 10.1002/anie.201107446 *

Also Published As

Publication number Publication date
CN110590802B (en) 2021-02-02
CN110590802A (en) 2019-12-20

Similar Documents

Publication Publication Date Title
Lévesque et al. Continuous‐flow synthesis of the anti‐malaria drug artemisinin
US20210163387A1 (en) One-step flow-mediated synthesis of cannabidiol (cbd) and derivatives
Bhattacharjee et al. Synthesis of side chain truncated apicularen A
CN106188078B (en) A kind of synthetic method of chiral spiro hydroxyindole benzopyrone and 3,4 dihydropyrane compounds
JP2017520586A (en) Synthesis and use of halichondrin analogues
Fattorusso et al. Antimalarials based on the dioxane scaffold of plakortin. A concise synthesis and SAR studies
WO2021052225A1 (en) Chemical semi-synthesis method for artemisinin
CN108640968A (en) A kind of meroterpenoids compound and its purposes in preparing anti-inflammatory drug
Kletskov et al. Synthesis and biological activity of novel comenic acid derivatives containing isoxazole and isothiazole moieties
KR20140041610A (en) Hyperforin analogs, methods of synthesis, and uses thereof
Stanoeva et al. Natural and synthetic cage compounds incorporating the 2, 9, 10-trioxatricyclo [4.3. 1.03, 8] decane type moiety
Tamura et al. Concise synthesis of 5, 6-dihydrovaltrate leading to enhanced Rev-export inhibitory congener
CN114230504B (en) Synthetic method of pyrrolidone intermediate
CN114349813B (en) Preparation method of cherokee rose fruit sapogenin structure modification compound
Reddy et al. Sequential glycosylation/endo-dig cyclization of sugar enynones for the synthesis of pyrano [3, 2-c] furan scaffolds
Reddy et al. Tandem vinylcyclopropane ring opening/Prins cyclization for the synthesis of 2, 3-disubstituted tetrahydropyrans
EP2660234A1 (en) Process for the production of artemisinin intermediates
Berner et al. Antiviral. 1. 2-(. alpha.-hydroxybenzyl) imidazo [4, 5-c] pyridine
Long et al. Total synthesis of Asperchalasine A
Mehta et al. Enantioselective total synthesis of the polyketide natural product (−)-EI-1941-2: a novel interleukin-1β converting enzyme (ICE) inhibitor
EP2565197A1 (en) Method and device for the synthesis of artemisinin
NIU et al. Enhancing bioactivities and chemical properties of A marine briarane-type diterpenoid with late-stage diversification
CN115160399B (en) Soap-skin acid compound, preparation method and medical application thereof
CN116162076B (en) Spirocyclic gamma-butyrolactone containing carboxylic acid tert-butyl ester and 1, 3-indene diketone structure and preparation method thereof
CN115124472B (en) Indolizole compound and photoinduced synthesis method thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20866159

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20866159

Country of ref document: EP

Kind code of ref document: A1